Connection

Suniti Misra to Antineoplastic Agents

This is a "connection" page, showing publications Suniti Misra has written about Antineoplastic Agents.
Connection Strength

0.538
  1. Novel dual cyclooxygenase and lipoxygenase inhibitors targeting hyaluronan-CD44v6 pathway and inducing cytotoxicity in colon cancer cells. Bioorg Med Chem. 2013 May 01; 21(9):2551-9.
    View in: PubMed
    Score: 0.245
  2. Hyaluronan oligosaccharides as a potential anticancer therapeutic. Curr Pharm Biotechnol. 2008 Aug; 9(4):249-52.
    View in: PubMed
    Score: 0.178
  3. Novel di-tertiary-butyl phenylhydrazones as dual cyclooxygenase-2/5-lipoxygenase inhibitors: synthesis, COX/LOX inhibition, molecular modeling, and insights into their cytotoxicities. Bioorg Med Chem Lett. 2014 Jan 01; 24(1):317-24.
    View in: PubMed
    Score: 0.064
  4. Regulation of multidrug resistance in cancer cells by hyaluronan. J Biol Chem. 2003 Jul 11; 278(28):25285-8.
    View in: PubMed
    Score: 0.031
  5. Roles and targeting of the HAS/hyaluronan/CD44 molecular system in cancer. Matrix Biol. 2017 05; 59:3-22.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.